{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-331488","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2026-08-04T10:50:18+00:00","discovered_at":"2026-08-04T10:55:01.405487+00:00","generated_at":"2026-08-04T10:55:26.492838+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pediatrix Q2 2026: Adjusted EPS $0.63, revenue $488M, reaffirms FY EBITDA $280-300M","bullets":["Net revenue $487.8M, up 4.0% YoY; net income $39.8M ($0.49 diluted EPS) vs $39.3M ($0.46) YoY.","Adjusted EPS $0.63 vs $0.53 YoY; Adjusted EBITDA $76.4M vs $73.2M YoY.","Same-unit revenue up 1.9% (reimbursement +4.0%, volume -2.1%); NICU days down 3.2%.","Reaffirmed FY 2026 Adjusted EBITDA guidance of $280M-$300M.","Used $42.7M for share repurchases in Q2; total debt $584M, cash $288.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-331488","json":"https://secwatch.observer/filing/0001193125-26-331488.json","markdown":"https://secwatch.observer/filing/0001193125-26-331488.md","text":"https://secwatch.observer/filing/0001193125-26-331488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000119312526331488/0001193125-26-331488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000119312526331488/md-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T10:55:26.492838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}